Table 4.
(B) | 95% CI | Partial R | (R2) | p | |
---|---|---|---|---|---|
(µmol/L) 1 | 51.35 | 49.36, 53.34 | <0.001 | ||
Lycopene | −6.638 | −7.778, −5.499 | −0.248 | 0.059 | <0.001 |
α-Tocopherol | 0.289 | 0.229, 0.348 | 0.208 | 0.042 | <0.001 |
α-Carotene | −5.761 | −8.012, −3.524 | −0.112 | 0.011 | <0.001 |
β-Cryptoxanthin | 5.062 | 3.302, 6.823 | 0.125 | 0.011 | <0.001 |
(µmol/mmol) 2 | 53.03 | 50.64, 55.41 | <0.001 | ||
Lycopene/Cholesterol | −39.15 | −45.64, −32.65 | −0.256 | 0.076 | <0.001 |
α-Tocopherol/Cholesterol | 1.394 | 1.009, 1.780 | 0.157 | 0.022 | <0.001 |
α-Carotene/Cholesterol | −36.32 | −48.68, −23.96 | −0.128 | 0.011 | <0.001 |
β-Cryptoxanthin/Cholesterol | 25.85 | 16.21, 35.49 | 0.117 | 0.012 | <0.001 |
1 Multiple regression analyses (forward stepwise approach) with age (years) as the dependent variable; all measured biomarkers including cholesterol were assessed as covariates in the initial model (n = 2118), sum R = 0.350, sum R2 = 0.123; 2 Biomarkers adjusted for cholesterol (µmol/mmol) were assessed in the initial model (n = 1993); sum R = 0.348, sum R2 = 0.121. Regression coefficient B represents higher (+)/lower (−) age (years) with each unit (µmol/L or µmol/mmol) increase in respective compounds, e.g., per 1 µmol/L increase in lycopene, mean age was 6.6 years lower (−6.638 years).